33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2150408
176282
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtener premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

23 feb 2012 año - Ado-Trastuzumab Emtansine (T-DM1) Approved

Descripción:

FDA approves Ado-Trastuzumab Emtansine (T-DM1) for the treatment of patients with metastatic HER2-positive breast cancer. HER2 makes up 20% of all cases for breast cancer.

Añadido al timeline:

Cancer Timeline

ByGabriel Tackett
15 nov 2018
0
0
354

fecha:

23 feb 2012 año
Ahora mismo
~ 13 years ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL